Publicaciones en las que colabora con Francisco J. Blanco García (12)

2022

  1. Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

    Reumatologia Clinica, Vol. 18, Núm. 10, pp. 567-573

2021

  1. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

    European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382

2020

  1. Artrosis

    Medicina interna [19ª ed.] (Elsevier España)

  2. Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis

    Reumatologia Clinica, Vol. 16, Núm. 4, pp. 272-281

2019

  1. Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial

    Arthritis and Rheumatology, Vol. 71, Núm. 10, pp. 1616-1625

2018

  1. Recommendations for the use of parenteral methotrexate in rheumatic diseases

    Reumatologia Clinica, Vol. 14, Núm. 3, pp. 142-149

  2. Tratado de enfermedades reumáticas de la SER

    Editorial Médica Panamericana

2017

  1. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

  2. Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexate

    Reumatologia Clinica, Vol. 13, Núm. 3, pp. 127-138

2011

  1. Estudio descriptivo de la utilización de los FAMES en los pacientes con artritis reumatoide o artritis persistente que inician tratamiento farmacológico en España.(ESTUDIO FIRST)

    Reumatologia Clinica, Vol. 7, Núm. 2, pp. 88-93

2010

  1. Artrosis: fisiopatología, diagnóstico y tratamiento

    Editorial Médica Panamericana

2004

  1. Manual SER de las Enfermedades Reumáticas

    Editorial Médica Panamericana S.A.